0
Sign In
|
POL Subscriptions
Home
DSM Library
DSM-IV-TR®
DSM-IV-TR® Handbook of Differential Diagnosis
DSM Cases
Books
The American Psychiatric Publishing Textbook of Psychiatry
Gabbard's Treatments of Psychiatric Disorders
Textbook of Psychotherapeutic Treatments
The American Psychiatric Publishing Textbook of Geriatric Psychiatry
Dulcan's Textbook of Child and Adolescent Psychiatry
The American Psychiatric Publishing Textbook of Substance Abuse Treatment
The American Psychiatric Publishing Textbook of Psychopharmacology
Manual of Clinical Psychopharmacology
Textbook of Traumatic Brain Injury
Journals
The American Journal of Psychiatry
Psychiatric Services
The Journal of Neuropsychiatry and Clinical Neurosciences
Academic Psychiatry
FOCUS
Psychiatric News
Topics
APA Guidelines
CME & Self-Assessment
News
For Patients
What Your Patients Need to Know About Psychiatric Medications
Helping Parents, Youth, and Teachers Understand Medications for Behavioral and Emotional Problems: A Resource Book of Medication Information Handouts
Let's Talk Facts
My POL
Advanced Search
Home
Current Issue
All Issues
Topics
13
The American Journal of Psychiatry, VOL. 161, No. 11
1
AJP
Letter to the Editor
|
November 01, 2004
Vardenafil Reversal of Female Anorgasmia
ADAM KELLER ASHTON, M.D.
Am J Psychiatry 2004;161:2133-2133.
10.1176/appi.ajp.161.11.2133
Article
References
text
A
A
A
To the Editor: Selective serotonin reuptake inhibiting (SSRI) antidepressants commonly produce iatrogenic sexual dysfunction
+
(1
,
+
2)
. It is uncommon for spontaneous remission of this side effect to occur, even after taking the SSRI for years
+
(3)
. A variety of augmentation strategies have been proposed to reverse SSRI-induced sexual dysfunction
+
(4)
. Sildenafil has been used to reverse SSRI-induced anorgasmia in a woman
+
(5)
. Vardenafil, a phosphodiesterase type-5 inhibitor, is indicated in the treatment of male erectile disorder. I report here a case of SSRI-induced anorgasmia in a woman that was reversed by vardenafil.
Ms. A was a 37-year-old Caucasian woman who was successfully treated for panic disorder without agoraphobia and for generalized anxiety disorder with sertraline, 100 mg/day, for over 2 years after difficulty tolerating trials of alprazolam and clonazepam. Unfortunately, she developed anorgasmia from the sertraline within 3 months of reaching this dose. A dose reduction to 50 mg/day led to relapse, although her anorgasmia improved. Sildenafil augmentation 1 hour before sexual activity reversed her anorgasmia but only at the 100-mg dose; the 50-mg dose was ineffective. The anorgasmia persisted if she forgot to take sildenafil. The cost, however, was prohibitive because the drug was not covered by her health insurance. She was interested in trying vardenafil instead because it cost less than sildenafil. She found that vardenafil in the 10-mg strength was not only effective in reversing anorgasmia but was also more affordable because she could break the 20-mg pills in half. Ms. A could not detect any difference in the onset of action, the duration of effect, or adverse reactions from vardenafil compared to what she felt while taking sildenafil. Vardenafil has continued to be effective when she uses it once or twice a week for 9 months to date without any difficulty tolerating it.
This case report describes a woman with SSRI-induced anorgasmia and no other sexual complaints who had this side effect reversed by vardenafil. It is possible that this response was a placebo effect, although it is unlikely since this side effect persisted with a low dose of sildenafil. Larger-scale placebo-controlled studies would be helpful in determining the effect size and whether other opportunities exist for using vardenafil to reverse SSRI-induced sexual dysfunction.
At this point, vardenafil has been approved by the Food and Drug Administration only for use in men. Further studies in women with primary or secondary sexual dysfunction may reveal other populations and medical conditions that are responsive to vardenafil treatment. This report suggests that augmentation with vardenafil may assist some patients with SSRI-induced sexual dysfunction.
References
References
1
+
Ashton AK, Hamer R, Rosen RC: Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther 1997; 23:165–175
[PubMed]
[CrossRef]
2
+
Clayton AH, Pradko JF, Croft HA, Montano V, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A: Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002; 63:357–366
[PubMed]
[CrossRef]
3
+
Ashton AK, Rosen RC: Accommodation to serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Marital Ther 1998; 24:191–192
[PubMed]
[CrossRef]
4
+
Ashton AK, Young CM, LoPiccolo J: Premature ejaculation and male orgasmic disorder, in Treatment of Psychiatric Disorders, 3rd ed. Edited by Gabbard GO. Washington, DC, American Psychiatric Press, 2001, pp 1911–1933
5
+
Ashton AK: Sildenafil treatment of paroxetine-induced anorgasmia in a woman (letter). Am J Psychiatry 1999; 156:800
+
1
+
Ashton AK, Hamer R, Rosen RC: Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther 1997; 23:165–175
[PubMed]
[CrossRef]
2
+
Clayton AH, Pradko JF, Croft HA, Montano V, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A: Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002; 63:357–366
[PubMed]
[CrossRef]
3
+
Ashton AK, Rosen RC: Accommodation to serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Marital Ther 1998; 24:191–192
[PubMed]
[CrossRef]
4
+
Ashton AK, Young CM, LoPiccolo J: Premature ejaculation and male orgasmic disorder, in Treatment of Psychiatric Disorders, 3rd ed. Edited by Gabbard GO. Washington, DC, American Psychiatric Press, 2001, pp 1911–1933
5
+
Ashton AK: Sildenafil treatment of paroxetine-induced anorgasmia in a woman (letter). Am J Psychiatry 1999; 156:800
+
+
CME Activity
There is currently no quiz available for this resource. Please
click here to go to the CME page
to find another.
Loading...
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.
*
= Required Field
Comment Author(s)
*
(if multiple authors, separate names by comma)
Example: John Doe
Affiliation & Institution
*
Comment Title
*
Comment
*
Cancel
Print
PDF
E-mail
Recipient(s) will receive an email with a link (good for 72 hours) to '
Vardenafil Reversal of Female Anorgasmia
' and do not need to have American Journal of Psychiatry account to access the content.
Your Name:
*
Example: John Doe
Email Address:
*
CC Me:
Enter your valid email address. Example: jdoe@example.com
Recipient's Email Address:
*
Separate multiple email address with semi-colons (up to 5).
Subject:
*
's American Journal of Psychiatry: 'Vardenafil Reversal of Female Anorgasmia'
Subject for your email.
Message:
(Optional, message will truncate at 1000 characters)
Processing your request... Please Wait...
Copyright © in the material you requested is held by The American Psychiatric Association (unless otherwise noted). This email ability is provided as a courtesy, and by using it you agree that you are requesting the material solely for personal, non-commercial use, and that it is subject to The American Psychiatric Association's
Terms of Use
. The information provided in order to email this topic will not be used to send unsolicited email, nor will it be furnished to third parties. Please refer to The American Psychiatric Association's
Privacy Policy
for further information.
Copyright © American Psychiatric Association. All rights reserved.
Share
Get Citation
ADAM KELLER ASHTON; Vardenafil Reversal of Female Anorgasmia. American Journal of Psychiatry. 2004 Nov;161(11):2133-2133.
Download citation file:
RIS (Zotero)
EndNote
BibTex
Medlars
ProCite
RefWorks
Reference Manager
Copyright © American Psychiatric Association. All rights reserved.
Reprints
Related Content
Articles
Efficacy and Tolerability of Vardenafil in Men With Mild Depression and Erectile Dysfunction: The Depression-Related Improvement With Vardenafil for Erectile Response Study
Am J Psychiatry 1 January 2006: Vol. 163. no. 1, pp. 79-87
[+] View More
Books
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 42. >
Sexual Dysfunctions
DSM-IV-TR® Diagnostic and Statistical Manual of Mental Disorders > Chapter 11. >
Sexual and Gender Identity Disorders
[+] View More
Topic Collections
Sexual Disorders
You do not have access to this content.
You either do not have a subscription or your subscription has expired.
Click here
to Renew Now
Copyright ©
American
Psychiatric
Association